As of July 1, it removed Zepbound from its formulary, which required most patients to switch to Wegovy, regardless of which drug works better for them
Less common, more critical The serious side effects listed in the safety warnings for semaglutide and tirzapetide include changes in vision, while tirzapetide lists the possibility of diabetic retinopathy complications
GLP-1 drugs are associated with a higher risk of wet age-related macular degeneration in people with type 2 diabetes, according to a new study
the receptors are also found on tissues throughout the body, including the lungs, kidneys, nervous system, cardiovascular system, gastrointestinal tract, skin, and vagus nerve
These drugs offer substantial potential health benefits, but the combination of intense demand, new uses, and high prices for these treatments is likely to place tremendous pressure on Medicare spending, Part D plan costs, and premiums for Part D coverage.